Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion

NCT02398656 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT02398656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02398656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Lead sponsor
University of Calgary
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2015
Completion date
April 10, 2024
Enrollment
1,274 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute